BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 14658923)

  • 1. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.
    Korppi M
    Paediatr Drugs; 2003; 5(12):821-32. PubMed ID: 14658923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and treatment of community-acquired pneumonia in ambulatory children.
    Wubbel L; Muniz L; Ahmed A; Trujillo M; Carubelli C; McCoig C; Abramo T; Leinonen M; McCracken GH
    Pediatr Infect Dis J; 1999 Feb; 18(2):98-104. PubMed ID: 10048679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
    Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
    Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
    Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-Acquired Pneumonia in Children.
    Leung AKC; Wong AHC; Hon KL
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):136-144. PubMed ID: 29932038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elderly patients with community-acquired pneumonia: optimal treatment strategies.
    Thiem U; Heppner HJ; Pientka L
    Drugs Aging; 2011 Jul; 28(7):519-37. PubMed ID: 21721597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of childhood pneumonia.
    Nascimento-Carvalho CM
    Expert Opin Pharmacother; 2010 Feb; 11(2):225-31. PubMed ID: 20088744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of azithromycin as the empiric therapy in children with community-acquired pneumonia who were isolated macrolide resistant Streptococcus pneumoniae from nasopharynx].
    Nariai A; Okitsu N; Inoue M
    Kansenshogaku Zasshi; 2004 Jun; 78(6):490-5. PubMed ID: 15287476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
    Harris JA; Kolokathis A; Campbell M; Cassell GH; Hammerschlag MR
    Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan.
    Chen CJ; Lin PY; Tsai MH; Huang CG; Tsao KC; Wong KS; Chang LY; Chiu CH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2012 Nov; 31(11):e196-201. PubMed ID: 22935863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiology of community-acquired pneumonia: serological results of a paediatric survey.
    Don M; Fasoli L; Paldanius M; Vainionpää R; Kleemola M; Räty R; Leinonen M; Korppi M; Tenore A; Canciani M
    Scand J Infect Dis; 2005; 37(11-12):806-12. PubMed ID: 16308213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
    He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):576-581. PubMed ID: 38858211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of pneumonia in children.
    McCracken GH
    Pediatr Infect Dis J; 2000 Sep; 19(9):924-8. PubMed ID: 11001128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial therapy of pneumonia in infants and children.
    Harris JA
    Semin Respir Infect; 1996 Sep; 11(3):139-47. PubMed ID: 8883171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
    Dinur-Schejter Y; Cohen-Cymberknoh M; Tenenbaum A; Brooks R; Averbuch D; Kharasch S; Kerem E
    Pediatr Pulmonol; 2013 Jan; 48(1):52-8. PubMed ID: 22431471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.